KRAS is the most commonly activated oncogene in CRC, with mutations occurring in exon 2 codon 12 and 13, exon 3 codon 59 and 61, and exon 4 codon 117 and 146 [16,57]. This evidence concerns the gene KRAS and colorectal carcinoma.